Dengue Virus and Zika Virus Seroprevalence in the South Pacific Populations of the Cook Islands and Vanuatu.
Humans
Zika Virus Infection
/ epidemiology
Seroepidemiologic Studies
Dengue Virus
/ immunology
Zika Virus
/ immunology
Vanuatu
/ epidemiology
Dengue
/ epidemiology
Polynesia
/ epidemiology
Antibodies, Viral
/ blood
Adult
Female
Adolescent
Young Adult
Male
Middle Aged
Aged
Child
Enzyme-Linked Immunosorbent Assay
Child, Preschool
Immunoglobulin G
/ blood
Infant
South Pacific
Zika
arboviruses
chikungunya
dengue
island populations
seroprevalence
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
19 May 2024
19 May 2024
Historique:
received:
20
03
2024
revised:
30
04
2024
accepted:
09
05
2024
medline:
25
5
2024
pubmed:
25
5
2024
entrez:
25
5
2024
Statut:
epublish
Résumé
Arboviral diseases are serious threats to global health with increasing prevalence and potentially severe complications. Significant arthropod-borne viruses are the dengue viruses (DENV 1-4), the Zika virus (ZIKV), and the chikungunya virus (CHIKV). Among the areas most affected is the South Pacific Region (SPR). Here, arboviruses not only cause a high local burden of disease, but the region has also proven to contribute to their global spread. Outpatient serum samples collected between 08/2016 and 04/2017 on three islands of the island states of Vanuatu and the Cook Islands were tested for anti-DENV- and anti-ZIKV-specific antibodies (IgG) using enzyme-linked immunosorbent assays (ELISA). ELISA test results showed 89% of all test sera from the Cook Islands and 85% of the Vanuatu samples to be positive for anti-DENV-specific antibodies. Anti-ZIKV antibodies were identified in 66% and 52%, respectively, of the test populations. Statistically significant differences in standardized immunity levels were found only at the intranational level. Our results show that in both the Cook Islands and Vanuatu, residents were exposed to significant
Identifiants
pubmed: 38793688
pii: v16050807
doi: 10.3390/v16050807
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : ADEMED e.V. (https://www.ademed.de/), a non-profit society to support research in travel medicine
ID : 180627
Organisme : Bundeswehr Institute of Microbiology, Munich
ID : funding: materials and use of their laboratory [no grant / grant number]